Buspirone for management of dyspnea in cancer patients receiving chemotherapy: a randomized placebo-controlled URCC CCOP study.
about
Study protocol: a phase III randomised, double-blind, parallel arm, stratified, block randomised, placebo-controlled trial investigating the clinical effect and cost-effectiveness of sertraline for the palliative relief of breathlessness in people wNon-opioid medications for the relief of chronic breathlessness: current evidence.
P2860
Buspirone for management of dyspnea in cancer patients receiving chemotherapy: a randomized placebo-controlled URCC CCOP study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Buspirone for management of dy ...... bo-controlled URCC CCOP study.
@ast
Buspirone for management of dy ...... bo-controlled URCC CCOP study.
@en
type
label
Buspirone for management of dy ...... bo-controlled URCC CCOP study.
@ast
Buspirone for management of dy ...... bo-controlled URCC CCOP study.
@en
prefLabel
Buspirone for management of dy ...... bo-controlled URCC CCOP study.
@ast
Buspirone for management of dy ...... bo-controlled URCC CCOP study.
@en
P2093
P2860
P1476
Buspirone for management of dy ...... ebo-controlled URCC CCOP study
@en
P2093
Charles E Heckler
Deborah J Dudgeon
Gary R Morrow
Jeffrey J Kirshner
Joseph A Roscoe
Judith O Hopkins
Luke L Peppone
Marie A Flannery
Peter W Bushunow
Shaker R Dakhil
P2860
P2888
P304
P356
10.1007/S00520-015-2903-6
P577
2015-09-02T00:00:00Z